http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2015000185-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2015-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9767c30122d848de4d06ea0f898fd1da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd9cfed139db5cf7e168dc6f03822fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79131047db83f459ec3fb77029c58c6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bab0e369965f4fa2342cbf599cb55e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d717140085a28edae0e3d66a63194acc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cbb75de0a5f89b604bd3fb9816a0cc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cfdf45729bce86f7bf6403344dedf6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97abf2a43f4adb95e6b851ffd2f8ef58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8236ceb6fb0cfc9408e6d429e15292a4
publicationDate 2016-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2015000185-A1
titleOfInvention 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
abstract The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).
priorityDate 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431392419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90103260

Total number of triples: 30.